We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.02B
AUM Growth
-$1.32M
Cap. Flow
-$27.2M
Cap. Flow %
-2.65%
Top 10 Hldgs %
36.57%
Holding
447
New
77
Increased
110
Reduced
140
Closed
93

Top Sells

Rank Stock Value
1
DEN
Denbury Inc.
DEN
+$28.4M
2
AR icon
Antero Resources
AR
+$22.5M
3
IMO icon
Imperial Oil
IMO
+$11.8M
4
ABBV icon
AbbVie
ABBV
+$9.22M
5
DAC icon
Danaos Corp
DAC
+$8.26M

Sector Composition

Rank Sector Weight
1 Energy 35.09%
2 Technology 13.02%
3 Healthcare 11.46%
4 Industrials 9.72%
5 Financials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSYS icon
401
Stratasys
SSYS
$697M
-13,375
Closed -$250K
THRM icon
402
Gentherm
THRM
$1.31B
-7,179
Closed -$448K
TROW icon
403
T. Rowe Price
TROW
$25B
-2,224
Closed -$253K
TWST icon
404
Twist Bioscience
TWST
$5.62B
-13,552
Closed -$473K
TXN icon
405
Texas Instruments
TXN
$255B
-49,648
Closed -$7.63M
URI icon
406
United Rentals
URI
$71.1B
-991
Closed -$241K
VNOM icon
407
Viper Energy
VNOM
$8.81B
-32,547
Closed -$869K
VRNT
408
DELISTED
Verint Systems
VRNT
-7,624
Closed -$323K
WAL icon
409
Western Alliance Bancorporation
WAL
$9.07B
-4,932
Closed -$348K
ITCI
410
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-36,414
Closed -$2.08M
PRFT
411
DELISTED
Perficient Inc
PRFT
-6,250
Closed -$573K
CERE
412
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-22,824
Closed -$604K
AGTI
413
DELISTED
Agiliti Inc
AGTI
-61,919
Closed -$1.27M
LGVCW
414
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
-67,425
Closed -$5K
AEON.WS
415
DELISTED
AEON Biopharma Inc
AEON.WS
-50,119
Closed -$8K
LCAAW
416
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
-58,345
Closed -$6K
FTCH
417
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-22,359
Closed -$160K
VRTV
418
DELISTED
VERITIV CORPORATION
VRTV
-4,138
Closed -$449K
AVID
419
DELISTED
Avid Technology Inc
AVID
-41,822
Closed -$1.08M
AAC.WS
420
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
-65,280
Closed -$15K
FORG
421
DELISTED
ForgeRock, Inc.
FORG
-27,782
Closed -$595K
UTAAW
422
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
-55,405
Closed -$21K
PNTM.WS
423
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
-72,105
Closed -$10K
USER
424
DELISTED
UserTesting, Inc.
USER
-18,476
Closed -$93K
SGHC.WS
425
DELISTED
Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share
SGHC.WS
-16,719
Closed -$10K

Similar funds

Advisory Research's Q3 2022 Portfolio in Review

As of Q3 2022, Advisory Research held 447 positions worth $1.02B, down 0.13% from $1.02B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Advisory Research's Q3 2022 filing shows 77 new, 110 increased, 140 reduced and 93 closed positions. Its largest new stake was Velo3D, Inc.: 38,954 shares worth $5.37M. The largest sale was Denbury Inc., an estimated $28.4M.

By sector, the portfolio is most concentrated in Energy at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

  • Advisory Research's largest Q3 2022 buy was Velo3D, Inc.: 38,954 shares worth $5.37M.
  • Advisory Research added most to Equinor in Q3 2022, an estimated $9.87M increase.
  • Advisory Research's biggest Q3 2022 reduction was Denbury Inc., cutting an estimated $28.4M.
  • Advisory Research fully exited Imperial Oil in Q3 2022, selling an estimated $11.8M.
  • Advisory Research's ten largest holdings make up 37% of its $1.02B portfolio in Q3 2022.
  • Advisory Research opened 77 new positions and closed 93 in Q3 2022.
  • Advisory Research's portfolio value fell 0.13% quarter-over-quarter to $1.02B.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.